NCT01758523View on ClinicalTrials.gov

Dutasteride Treatment for the Reduction of Heavy Drinking in Men

PHASE4CompletedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
AlcoholismAlcohol AbuseAlcohol Dependence
Interventions
DRUG

Dutasteride

DRUG

sugar pill

Trial Locations (1)

06030

University of Connecticut Health Center, Farmington

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

UConn Health

OTHER

NCT01758523 - Dutasteride Treatment for the Reduction of Heavy Drinking in Men | Biotech Hunter | Biotech Hunter